Literature DB >> 8119716

Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category.

F P O'Malley1, D L Page, E H Nelson, W D Dupont.   

Abstract

Papillary patterns of apocrine cells are frequent in benign breast biopsies and pose little diagnostic difficulty when the classic apocrine cytology is present. Dilemmas in diagnosis do occur, however, when the usual papillary patterns of hyperplastic apocrine epithelium are absent in hyperplastic lesion, particularly if it is extensive, presents more complex patterns, and/or lacks usual nuclear features. We classified lesions with nonclassic apocrine features into diagnostic categories to separate those with malignant potential from those that are truly benign. We selected 54 such cases sent in consultation over a 2-year period (1989 to 1991). We applied two sets of criteria: nuclear patterns (usual, borderline, and as seen in ductal carcinoma in situ) and extent of lesion (< mm, 4 to 8 mm, and > 8 mm). The cases were categorized into diagnostic groups defined by these criteria of extent of lesion and cytologic features. We believe that application of these criteria recognizing borderline features to unusual, apocrine lesions fosters reproducibility in diagnosis and thus predictability of clinical outcome. We found only 10 cases to fit into borderline categories after use of the two criteria. The clinical utility of this suggested diagnostic stratification will require follow-up studies for linkage of criteria to clinical outcomes.

Entities:  

Mesh:

Year:  1994        PMID: 8119716     DOI: 10.1016/0046-8177(94)90273-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Multiplex PCR analysis of apocrine lesions shows frequent PI3K-AKT pathway mutations in both benign and malignant apocrine breast tumors.

Authors:  Naoki Kanomata; Rin Yamaguchi; Junichi Kurebayashi; Takuya Moriya
Journal:  Med Mol Morphol       Date:  2019-05-28       Impact factor: 2.309

Review 2.  [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].

Authors:  H-P Sinn; C Flechtenmacher; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 3.  The enigmatic nature of apocrine breast lesions.

Authors:  P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

4.  Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.

Authors:  C Jones; S Damiani; D Wells; R Chaggar; S R Lakhani; V Eusebi
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

5.  Encapsulated apocrine papillary carcinoma of the breast--a tumour of uncertain malignant potential: report of five cases.

Authors:  Melanie Seal; Christine Wilson; Gregory J Naus; Stephen Chia; Terry C Bainbridge; Malcolm M Hayes
Journal:  Virchows Arch       Date:  2009-10-28       Impact factor: 4.064

6.  [Atypical ductal hyperplasia and atypical epithelial proliferation of ductal type].

Authors:  W Böcker; D Hungermann; S Weigel; K Roterberg; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

7.  Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

Authors:  Jacqueline Lehmann-Che; Anne-Sophie Hamy; Raphaël Porcher; Marc Barritault; Fatiha Bouhidel; Hanadi Habuellelah; Solenne Leman-Detours; Anne de Roquancourt; Laurence Cahen-Doidy; Edwige Bourstyn; Patricia de Cremoux; Cedric de Bazelaire; Marcela Albiter; Sylvie Giacchetti; Caroline Cuvier; Anne Janin; Marc Espié; Hugues de Thé; Philippe Bertheau
Journal:  Breast Cancer Res       Date:  2013-05-11       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.